cheers

Still, Sinopharm may have a built-in edge given its established distribution networks within China and the fact that it is testing its vaccine in a broader array of countries than other Chinese vaccine makers.

"[Sinopharm's] large scale rollout [via China's emergency use program] also means that there is already a large distribution system, which has already been stress-tested," says Nicholas Thomas, a vaccine expert and health governance professor at the City University of Hong Kong. "This is a major advantage in the future distribution." Sinopharm is also already distributing vaccines to the United Arab Emirates via that country's emergency use program, and is testing, or plans to conduct trials, in at least ten countries including Egypt, Jordan, and Argentina.

correct? :)

https://www.ft.com/content/ac5e5ef8-bccb-482b-9f8d-0dab5cac6f9a

thanks NPRA

https://www.msn.com/en-my/news/national/k-star-sees-opportunity-in-distributing-covid-19-vaccines-to-private-clinics/ar-BB1blpsC

https://www.businesstoday.com.my/2020/11/23/kanger-international-moves-from-bamboo-flooring-to-covid-19-vaccine-distribution/

Sinopharm, a leading Chinese vaccine developer, has applied for a license to bring its COVID-19 vaccines to the market, the company's vice general manager Shi Shengyi told Xinhua Wednesday.

The application has been submitted to the National Medical Products Administration for review, Shi said. Once approved, it means the vaccines will be available for the general public.

https://news.cgtn.com/news/2020-11-25/Sinopharm-applies-to-bring-its-COVID-19-vaccine-to-market--VIiimRueZy/index.html

Therefore, the Sinopharm vaccine has been approved for emergency use for health workers in the UAE since September. Prime Minister of the UAE Sheikh Mohamed Bin Rashid Al Maktoum and other senior officials have also been inoculated.

Soon after, Bahrain also gave emergency approval for the Sinopharm vaccine and front-line workers there started getting inoculations this month. Notably, Bahrain’s crown prince, ministers and other senior officials have also received shots of the vaccine.

Endorsing its use, Bahrain’s Health Minister Faeqa bint Saeed Al Saleh said, “The results of phase 1 and phase 2 clinical trials showed the vaccine is safe and effective.” Apparently, no severe side effects have appeared during the late-testing stage and around 7,770 people have now received a second dose.



Read more: https://www.al-monitor.com/pulse/originals/2020/11/china-covid19-vaccine-diplomacy-treatment-phase3-trials.html#ixzz6fCCevi00

this counter will go up slowly because of its 2.255B shares and still cheap. so stay strong! :-) thanks for all positive views. forget all the negative

Posted by NPRA1985 > Nov 27, 2020 10:28 PM | Report Abuse

Yes Sinopharm vaccine is working quietly..... good points NPRA1985

https://www.theedgemarkets.com/article/procurement-use-covid19-vaccine-depend-five-aspects-%E2%80%94-health-dg

https://www.klsescreener.com/v2/news/view/757059/evening-5-five-things-you-need-to-know-today

ini kali lah Kanger :-)

https://www.astroawani.com/berita-dunia/lima-calon-vaksin-covid19-china-masuk-ujian-fasa-akhir-mungkin-lebih-murah-268987

another positive news

https://thevaccinetracker.com/

top two vaccine are from Sinopharm. All the best Kanger. stay strong guys!

another good venture right!

TAYOR guys :-)

yezza

Kanger will fly soon :-)

https://jakartaglobe.id/business/pfizers-vaccine-is-out-of-the-question-as-indonesia-lacks-refrigerators-state-pharma-boss

Vaksin China jadi pilihan

https://www.thesundaily.my/world/sinovac-coronavirus-vaccine-offered-by-chinese-city-for-emergency-use-costs-60-rm-249-MB4650790

again positive news for Kanger. Thanks NPRA1985

any relations between sinovac and sinopharm's vaccine?

with 2.5B shares, Kanger need to hit revenue around RM5B for TP RM2.

Posted by angelo > Nov 21, 2020 9:31 PM | Report Abuse

NPRA1985 n Noobie123
Lets be realistic. I like maths. Assuming the total shares in issuance is 2.5 billion and PE is 20. For its share price to achieve:
a. RM0.32, Profit=RM40 miilion, EPS=1.6 sen
b. RM2.00, Profit=RM250 million, EPS=10 sen
c. RM4.00, Profit=RM500 million, EPS=20 sen
d. RM10.00, Profit=RM1.5 billion, EPS=50 sen

(a) can be achieved easily
(b) possible but very hard
(c and d) you need a miracle

i like! well calculated. thanks angelo

https://www.poandpo.com/companies/sinopharm-cansino-and-sinovac-prepare-for-coronavirus-vaccine-transport/

https://www.thehealthsite.com/news/bahrain-starts-giving-sinopharm-covid-19-vaccine-to-frontline-health-workers-777349/

https://www.moroccoworldnews.com/2020/11/324663/uae-prime-minister-receives-sinopharm-covid-19-vaccine/

felt the same, will wait and see :-) tq mh87

gbt_9428 - Paktua will win :-)

mh87 - thanks for the positive comment

Based on the K1 business diversification, they will get beneficial from both vaccine and covid19.

K1 = EMS + CLOUD + HC

aamin